ChemoCentryx, Inc.
CCXI
CCXI was delisted on the 19th of October, 2022.
117 hedge funds and large institutions have $469M invested in ChemoCentryx, Inc. in 2019 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 39 increasing their positions, 32 reducing their positions, and 13 closing their positions.
69% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 13
57% more capital invested
Capital invested by funds: $298M → $469M (+$170M)
22% more repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 32
14% more call options, than puts
Call options by funds: $3.08M | Put options by funds: $2.7M
8% more funds holding
Funds holding: 108 → 117 (+9)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$58.7M |
| 2 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$28.9M |
| 3 |
CCM
Consonance Capital Management
New York
|
+$19.1M |
| 4 |
CG
Carmignac Gestion
Paris,
France
|
+$8.48M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$6.44M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
-$59.7M |
| 2 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$6.8M |
| 3 |
CCM
Cadence Capital Management
Boston,
Massachusetts
|
-$1.13M |
| 4 |
D.E. Shaw & Co
New York
|
-$1.01M |
| 5 |
BlackRock
New York
|
-$903K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
LCM
126
Landscape Capital Management
Englewood,
New Jersey
| – | -$112K | -10,285 | Closed |
|
127
Macquarie Group
Sydney, NSW 2000,
Australia
| – | -$41K | -3,800 | Closed |
|
|
PCM
128
Prelude Capital Management
New York
| – | -$12K | -1,076 | Closed |
|
|
AIC
129
Ameritas Investment Company
Lincoln,
Nebraska
| – | -$11K | -1,000 | Closed |
|
|
TRCT
130
Tower Research Capital (TRC)
New York
| – | -$3K | -257 | Closed |
|
CCXI Hedge Fund Activity: Q1 2019 in Review
117 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in ChemoCentryx, Inc. (CCXI) for Q1 2019, worth a combined $469M — up 57% from $298M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new CCXI positions and 13 closed out — a net gain of 9 holders — while 39 added to existing stakes and 32 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $58.7M. The largest seller was BVF Inc, cutting an estimated $59.7M.
- 117 institutional investors held ChemoCentryx, Inc. (CCXI) as of Q1 2019, up from 108 in Q4 2018.
- Funds reported $469M of ChemoCentryx, Inc. stock for Q1 2019, up 57% quarter-over-quarter.
- 22 funds opened new ChemoCentryx, Inc. positions in Q1 2019 and 13 closed out, a net change of +9 holders.
- The largest ChemoCentryx, Inc. buyer in Q1 2019 was Fidelity Investments, an estimated $58.7M added.
- The largest ChemoCentryx, Inc. seller in Q1 2019 was BVF Inc, an estimated $59.7M sold.
Based on aggregated 13F filings for Q1 2019.